AI assistant
Sending…
AEHR TEST SYSTEMS — Director's Dealing 2019
Jan 22, 2019
32300_dirs_2019-01-22_12ccc4d3-595a-484a-b7ce-6e62eec69a67.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2019-01-18
Reporting Person: ROSATI MARIO M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-18 | Common Stock | M | 30179 | $0.75 | Acquired | 33880 | Direct |
| 2019-01-18 | Common Stock | S | 30179 | $1.1298 | Disposed | 3701 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-18 | Non-Qualified Stock Option (right to buy) | $0.75 | M | 30179 | Disposed | 2019-01-31 | Common Stock (30179) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 151016 | Indirect |
| Common Stock | 23468 | Indirect |
| Common Stock | 22500 | Indirect |
| Common Stock | 27000 | Indirect |
Footnotes
F1: Shares held by Mario M. Rosati, Trustee of the Mario M. Rosati Trust U/D/T dated January 5, 1990.
F2: Shares held by Mario M. Rosati and Danelle Storm Rosati, Trustees of the Rosati Family Trust U/D/T dated May 23, 1997.
F3: Shares held by WS Investment Company, LLC (2001A), for which Mr. Rosati is a general partner.
F4: One sixth (1/6) of the total number of shares became exercisable on this date and an additional one sixth (1/6) of the total number of shares became exercisable each month thereafter.
More from AEHR TEST SYSTEMS
Capital/Financing Update
2026
Apr 20
Capital/Financing Update
2026
Apr 8
Earnings Release
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 4